1. Pomerantz LLP investigates potential securities fraud involving Harmony Biosciences. 2. Investors urged to contact the firm regarding unlawful business practices.
The investigation suggests possible serious misconduct, impacting investor confidence and stock price. Similar past cases have led to significant declines for affected companies.
Ongoing legal investigations can severely affect stock prices and market perception, making this news highly relevant for HRMY investors.
The news can trigger immediate sell-offs as investors digest the implications of the investigation.